J.P. Morgan Private Wealth Advisors LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 203 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.

Quarter-by-quarter ownership
J.P. Morgan Private Wealth Advisors LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$1,051,000
+80.0%
15,431
-15.6%
0.00%
+200.0%
Q2 2022$584,000
-14.6%
18,278
-7.4%
0.00%0.0%
Q1 2022$684,000
+6.0%
19,738
-10.4%
0.00%0.0%
Q4 2021$645,000
+9.0%
22,027
-5.2%
0.00%0.0%
Q3 2021$592,000
-28.8%
23,223
-2.1%
0.00%
-50.0%
Q2 2021$831,000
-45.3%
23,727
-36.4%
0.00%
-60.0%
Q1 2021$1,520,000
-12.5%
37,301
-7.0%
0.01%
-16.7%
Q4 2020$1,737,000
-20.4%
40,105
+1.3%
0.01%
-33.3%
Q3 2020$2,182,000
+65.1%
39,575
+89.0%
0.01%
+50.0%
Q2 2020$1,322,000
+26.1%
20,935
+2.1%
0.01%0.0%
Q1 2020$1,048,000
+27.6%
20,511
+98.7%
0.01%
+50.0%
Q4 2019$821,000
+65.9%
10,323
+1.2%
0.00%
+33.3%
Q3 2019$495,000
+31.6%
10,196
+42.5%
0.00%
+50.0%
Q2 2019$376,000
-20.7%
7,153
-20.1%
0.00%0.0%
Q1 2019$474,000
+42.8%
8,947
+10.6%
0.00%0.0%
Q4 2018$332,000
-31.1%
8,093
-36.2%
0.00%0.0%
Q3 2018$482,000
+48.8%
12,688
+77.1%
0.00%0.0%
Q2 2018$324,000
-6.4%
7,1650.0%0.00%0.0%
Q1 2018$346,000
+13.1%
7,165
-8.0%
0.00%0.0%
Q4 2017$306,000
+29.1%
7,784
+2.1%
0.00%0.0%
Q3 2017$237,0007,6210.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2018
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders